Siskinds | The Law Firm

CLASS ACTION CATEGORIES

Browse a different category to find other class actions. Choisissez une autre catégorie afin de trouver d'autres recours collectifs.

FREQUENTLY ASKED QUESTIONS

Browse our answers to some of our frequently asked questions. Naviguez nos réponses à certaines questions fréquemment posées.
View Faqs
Pharmaceutical and Medical Devices > Current Actions > Depo-Provera
    Depo-Provera
    On December 13, 2005, Siskinds filed a class proceeding against Pfizer Canada Inc. and Pfizer Inc. with respect to Depo-Provera. Depo-Provera is typically prescribed to prevent pregnancy, however, it is also used to treat endometriosis and as a palliative treatment of certain cancers. Use of Depo-Provera has been associated with an increased risk of significant bone mineral density loss, including a significantly increased risk of developing osteoporosis at ages below the statistical norm.

    On May 28, 2008, the Superior Court of Quebec certified the action as a National Class. Any person who has taken Depo-Provera and has been affected with bone mineral density loss is part of the defined class.

    Siskinds is working cooperatively with the Quebec firm of Belleau Lapointe LLP

    For further information concerning this action, please contact Ruth Noble at 1-800-461-6166 ext. 2381 or e-mail Ruth by clicking on the Contact Us link below.
     


    Download Adobe reader

    The documents available on this page require the latest version of Adobe Acrobat Reader for viewing.Les documents disponibles sur cette page nécessitent la dernière version d’Adobe Acrobat Reader pour les visionner.
    Cliquez ici pour télécharger.Click Here to download.